Imcyse
Therapeutics
Imcyse has raised €35M across 1 funding round from 1 investor, most recently a Series B round in Apr 2019. Based in Liege, Belgium; active in Healthtech. Data as of 4 Nov 2026.
Liege, Belgiumwww.imcyse.com ↗
Total raised
€35M
€35,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2019-04
latest 2019-04
Funding by year
EUR raised per yearImcyse — funding by year — interactive chart.
Data table
| Imcyse — funding by year | |
|---|---|
| 2019 | €35M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-04-01 | Series B | €35M | LSP BioVentures | View deal → |
Investors
1Related news
Similar companies
same sector, similar size- Indigo Diabetes€38MBelgium · Healthtech
- Confo Therapeutics€30MBelgium · Healthtech
- Camel-IDS€37MBelgium · Healthtech
- Oncodna€19MBelgium · Healthtech
- Promethera Biosciences€47MBelgium · Healthtech
- CryoTherapeutics€29MBelgium · Healthtech
Global coverage: FundingData